PL2928896T3 - Stała postać pochodnej dihydropirydooksazyny - Google Patents
Stała postać pochodnej dihydropirydooksazynyInfo
- Publication number
- PL2928896T3 PL2928896T3 PL13824177T PL13824177T PL2928896T3 PL 2928896 T3 PL2928896 T3 PL 2928896T3 PL 13824177 T PL13824177 T PL 13824177T PL 13824177 T PL13824177 T PL 13824177T PL 2928896 T3 PL2928896 T3 PL 2928896T3
- Authority
- PL
- Poland
- Prior art keywords
- pyrido
- dihydro
- solid form
- oxazine derivative
- oxazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Dispersion Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GC201222895 | 2012-11-26 | ||
IR1391307213 | 2012-12-04 | ||
PCT/IB2013/060412 WO2014102630A1 (en) | 2012-11-26 | 2013-11-26 | Solid form of dihydro-pyrido-oxazine derivative |
EP13824177.3A EP2928896B1 (en) | 2012-11-26 | 2013-11-26 | Solid form of dihydro-pyrido-oxazine derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2928896T3 true PL2928896T3 (pl) | 2018-01-31 |
Family
ID=51019963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL13824177T PL2928896T3 (pl) | 2012-11-26 | 2013-11-26 | Stała postać pochodnej dihydropirydooksazyny |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP2928896B1 (pl) |
KR (1) | KR102184069B1 (pl) |
CN (1) | CN104870451B (pl) |
AU (1) | AU2013368997B8 (pl) |
BR (1) | BR112015009870A2 (pl) |
CA (1) | CA2891521A1 (pl) |
CL (1) | CL2015001409A1 (pl) |
CY (1) | CY1119702T1 (pl) |
DK (1) | DK2928896T3 (pl) |
GT (1) | GT201500124A (pl) |
HK (1) | HK1209419A1 (pl) |
IL (1) | IL238889B (pl) |
MX (1) | MX366342B (pl) |
NZ (1) | NZ706865A (pl) |
PE (1) | PE20150946A1 (pl) |
PH (1) | PH12015501052A1 (pl) |
PL (1) | PL2928896T3 (pl) |
PT (1) | PT2928896T (pl) |
SG (1) | SG11201503410VA (pl) |
TN (1) | TN2015000128A1 (pl) |
TW (1) | TW201422625A (pl) |
WO (1) | WO2014102630A1 (pl) |
ZA (1) | ZA201502350B (pl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2014CN04174A (pl) | 2011-12-22 | 2015-09-04 | Novartis Ag | |
WO2020035424A1 (en) | 2018-08-13 | 2020-02-20 | F. Hoffmann-La Roche Ag | New heterocyclic compounds as monoacylglycerol lipase inhibitors |
BR112022002375A2 (pt) | 2019-09-12 | 2022-07-19 | Hoffmann La Roche | Compostos de 4,4a,5,7,8,8a-hexapirido[4,3-b][1,4]oxazin-3-ona como inibidores de magl |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU11248A1 (ru) | 1927-03-29 | 1929-09-30 | В.С. Григорьев | Способ очистки антрацена |
GB1524747A (en) | 1976-05-11 | 1978-09-13 | Ici Ltd | Polypeptide |
ATE28864T1 (de) | 1982-07-23 | 1987-08-15 | Ici Plc | Amide-derivate. |
GB8327256D0 (en) | 1983-10-12 | 1983-11-16 | Ici Plc | Steroid derivatives |
US5093330A (en) | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
US5010099A (en) | 1989-08-11 | 1991-04-23 | Harbor Branch Oceanographic Institution, Inc. | Discodermolide compounds, compositions containing same and method of preparation and use |
NZ243082A (en) | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
GB9300059D0 (en) | 1992-01-20 | 1993-03-03 | Zeneca Ltd | Quinazoline derivatives |
TW225528B (pl) | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
GB9314893D0 (en) | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
EP1110953B1 (en) | 1995-03-30 | 2009-10-28 | Pfizer Products Inc. | Quinazoline derivatives |
GB9508538D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
US5843901A (en) | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
DK0836605T3 (da) | 1995-07-06 | 2002-05-13 | Novartis Ag | Pyrrolopyrimidiner og fremgangsmåder til deres fremstilling |
US5760041A (en) | 1996-02-05 | 1998-06-02 | American Cyanamid Company | 4-aminoquinazoline EGFR Inhibitors |
GB9603095D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
NZ332119A (en) | 1996-04-12 | 2001-08-31 | Warner Lambert Co | Quinazoline compounds which are irreversible inhibitors of tyrosine kinases |
DE69734513T2 (de) | 1996-06-24 | 2006-07-27 | Pfizer Inc. | Phenylamino-substituierte tricyclische derivate zur behandlung hyperproliferativer krankheiten |
JP2001500851A (ja) | 1996-08-30 | 2001-01-23 | ノバルティス アクチエンゲゼルシャフト | エポシロンの製造法および製造過程中に得られる中間生産物 |
CA2264908C (en) | 1996-09-06 | 2006-04-25 | Obducat Ab | Method for anisotropic etching of structures in conducting materials |
AU4342997A (en) | 1996-09-13 | 1998-04-02 | Sugen, Inc. | Use of quinazoline derivatives for the manufacture of a medicament in the reatment of hyperproliferative skin disorders |
EP0837063A1 (en) | 1996-10-17 | 1998-04-22 | Pfizer Inc. | 4-Aminoquinazoline derivatives |
HU229833B1 (en) | 1996-11-18 | 2014-09-29 | Biotechnolog Forschung Gmbh | Epothilone d production process, and its use as cytostatic as well as phytosanitary agents |
US6441186B1 (en) | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
CO4940418A1 (es) | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
GB9721069D0 (en) | 1997-10-03 | 1997-12-03 | Pharmacia & Upjohn Spa | Polymeric derivatives of camptothecin |
US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
NZ506742A (en) | 1998-02-25 | 2003-09-26 | Sloan Kettering Inst Cancer | Synthesis of desoxyepothilones and hydroxy acid derivative intermediates |
ATE459616T1 (de) | 1998-08-11 | 2010-03-15 | Novartis Ag | Isochinoline derivate mit angiogenesis-hemmender wirkung |
NZ511722A (en) | 1998-11-20 | 2004-05-28 | Kosan Biosciences Inc | Recombinant methods and materials for producing epothilone and epothilone derivatives |
PE20020354A1 (es) | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
NZ535616A (en) | 2000-11-07 | 2006-03-31 | Novartis Ag | Indolymaleimide derivatives as protein kinase c inhibitors |
AR035885A1 (es) | 2001-05-14 | 2004-07-21 | Novartis Ag | Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica |
GB0119249D0 (en) | 2001-08-07 | 2001-10-03 | Novartis Ag | Organic compounds |
PE20040079A1 (es) | 2002-04-03 | 2004-04-19 | Novartis Ag | Derivados de indolilmaleimida |
HUP0500844A2 (en) | 2002-12-09 | 2007-08-28 | Univ Texas | Methods for selectively inhibiting janus tyrosine kinase 3(jak3) |
PT1704145E (pt) | 2004-01-12 | 2012-09-04 | Ym Biosciences Australia Pty | Inibidores de quinase seletivos |
GB0510390D0 (en) | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
JP2009507072A (ja) * | 2005-09-07 | 2009-02-19 | ラボラトワール セローノ ソシエテ アノニム | 子宮内膜症の処置のためのpi3k阻害剤 |
GB0620059D0 (en) * | 2006-10-10 | 2006-11-22 | Ucb Sa | Therapeutic agents |
IN2014CN04174A (pl) * | 2011-12-22 | 2015-09-04 | Novartis Ag |
-
2013
- 2013-11-25 TW TW102142869A patent/TW201422625A/zh unknown
- 2013-11-26 EP EP13824177.3A patent/EP2928896B1/en active Active
- 2013-11-26 WO PCT/IB2013/060412 patent/WO2014102630A1/en active Application Filing
- 2013-11-26 PL PL13824177T patent/PL2928896T3/pl unknown
- 2013-11-26 BR BR112015009870A patent/BR112015009870A2/pt not_active Application Discontinuation
- 2013-11-26 DK DK13824177.3T patent/DK2928896T3/da active
- 2013-11-26 PE PE2015000687A patent/PE20150946A1/es not_active Application Discontinuation
- 2013-11-26 KR KR1020157013235A patent/KR102184069B1/ko active IP Right Grant
- 2013-11-26 SG SG11201503410VA patent/SG11201503410VA/en unknown
- 2013-11-26 CA CA2891521A patent/CA2891521A1/en not_active Abandoned
- 2013-11-26 CN CN201380061193.5A patent/CN104870451B/zh active Active
- 2013-11-26 NZ NZ706865A patent/NZ706865A/en not_active IP Right Cessation
- 2013-11-26 MX MX2015006650A patent/MX366342B/es active IP Right Grant
- 2013-11-26 AU AU2013368997A patent/AU2013368997B8/en not_active Ceased
- 2013-11-26 PT PT138241773T patent/PT2928896T/pt unknown
-
2015
- 2015-04-02 TN TNP2015000128A patent/TN2015000128A1/fr unknown
- 2015-04-08 ZA ZA2015/02350A patent/ZA201502350B/en unknown
- 2015-05-12 PH PH12015501052A patent/PH12015501052A1/en unknown
- 2015-05-18 IL IL238889A patent/IL238889B/en active IP Right Grant
- 2015-05-25 CL CL2015001409A patent/CL2015001409A1/es unknown
- 2015-05-26 GT GT201500124A patent/GT201500124A/es unknown
- 2015-10-14 HK HK15110054.5A patent/HK1209419A1/xx not_active IP Right Cessation
-
2017
- 2017-10-13 CY CY20171101078T patent/CY1119702T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CN104870451B (zh) | 2017-07-07 |
WO2014102630A1 (en) | 2014-07-03 |
BR112015009870A2 (pt) | 2017-12-05 |
GT201500124A (es) | 2016-03-01 |
SG11201503410VA (en) | 2015-05-28 |
PT2928896T (pt) | 2017-10-25 |
IL238889A0 (en) | 2015-07-30 |
AU2013368997A8 (en) | 2015-10-08 |
CY1119702T1 (el) | 2018-06-27 |
PH12015501052A1 (en) | 2015-07-27 |
AU2013368997B2 (en) | 2015-09-24 |
TN2015000128A1 (en) | 2016-10-03 |
EP2928896B1 (en) | 2017-07-19 |
CN104870451A (zh) | 2015-08-26 |
TW201422625A (zh) | 2014-06-16 |
KR20150091047A (ko) | 2015-08-07 |
MX2015006650A (es) | 2015-08-10 |
EP2928896A1 (en) | 2015-10-14 |
ZA201502350B (en) | 2017-08-30 |
KR102184069B1 (ko) | 2020-11-30 |
DK2928896T3 (da) | 2017-11-06 |
PE20150946A1 (es) | 2015-06-28 |
CL2015001409A1 (es) | 2015-07-24 |
CA2891521A1 (en) | 2014-07-03 |
HK1209419A1 (en) | 2016-04-01 |
NZ706865A (en) | 2016-04-29 |
IL238889B (en) | 2021-03-25 |
AU2013368997B8 (en) | 2015-10-08 |
MX366342B (es) | 2019-07-05 |
AU2013368997A1 (en) | 2015-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1212701A1 (zh) | 恩雜魯胺製劑 | |
HK1207375A1 (en) | Piperidinylpyrazolopyridine derivative | |
HK1207363A1 (en) | Novel indanesulfamide derivative | |
EP2917314A4 (en) | OLIGOMERATZUSAMMENSETZUNG | |
EP2800747A4 (en) | POLYMORPHY OF PERAMPANEL | |
IL236312A0 (en) | Preparation of 18f-flucyclobin | |
EP2881113A4 (en) | NEW APPLICATION OF POGOSTONE | |
HK1200824A1 (en) | Substituted phenylazole derivative | |
EP2892529A4 (en) | USES OF (-) - PERHEXILINE | |
PL2873660T3 (pl) | Pochodna indolokarboksyamidu | |
PL2807172T3 (pl) | Pochodne pirymidooksazocyny jako inhibitory mTOR | |
ZA201502350B (en) | Solid form of hihydro-pyrido-oxazine derivative | |
EP2842958A4 (en) | NAPHTHOBISTHIADIAZOLDERIVAT | |
HK1204621A1 (en) | 4-alkanoylamino-3-pyrazolone derivative 4--3- | |
SI2928896T1 (sl) | Trdna oblika derivata dihidro-pirido-oksazina | |
IL233446A0 (en) | Polymorphic forms of paramphenel | |
TWM433525U (en) | Structure of calorifier |